|
English
|
正體中文
|
简体中文
|
2823024
|
|
???header.visitor??? :
30240972
???header.onlineuser??? :
836
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"papp k a"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
臺大學術典藏 |
2018-09-10T15:28:29Z |
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Results from two randomized, placebo-controlled, phase III trials
|
Papp, K.A.;Menter, M.A.;Abe, M.;Elewski, B.;Feldman, S.R.;Gottlieb, A.B.;Langley, R.;Luger, T.;Thaci, D.;Buonanno, M.;Gupta, P.;Proulx, J.;Lan, S.;Wolk, R.; TSEN-FANG TSAI |
臺大學術典藏 |
2016 |
Efficacy of tofacitinib for the treatment of moderate-to-severe chronic plaque psoriasis in patient subgroups from two randomised phase 3 trials
|
Tan H.; TSEN-FANG TSAI; Gupta P.; Nadashkevich O.; Kaszuba A.; Menter M.A.; Papp K.A.; Cather J.; Leonardi C.; Pariser D.M.; Krueger J.G.; Wohlrab J.; Amaya-Guerra M.; Valdez H.; Mallbris L.; Tatulych S. |
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
|